サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：大動脈瘤の市場規模、シェア、動向分析レポート：タイプ別（TAA、AAA）、治療法別（OSR、EVAR）、製品別（ステントグラフト、カテーテル）、エンドユーザー別、地域別、セグメント予測、2022年～2030年
市場調査レポート
商品コード
1122255

大動脈瘤の市場規模、シェア、動向分析レポート：タイプ別（TAA、AAA）、治療法別（OSR、EVAR）、製品別（ステントグラフト、カテーテル）、エンドユーザー別、地域別、セグメント予測、2022年～2030年

Aortic Aneurysm Market Size, Share & Trends Analysis Report By Type (TAA, AAA), By Treatment (OSR, EVAR), By Product (Stent Grafts, Catheters), By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 140 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
大動脈瘤の市場規模、シェア、動向分析レポート：タイプ別（TAA、AAA）、治療法別（OSR、EVAR）、製品別（ステントグラフト、カテーテル）、エンドユーザー別、地域別、セグメント予測、2022年～2030年
出版日: 2022年08月04日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

大動脈瘤の市場成長・動向

株式会社グランド・ビュー・リサーチの最新レポートによると、大動脈瘤の世界市場規模は2030年までに65億米ドルに達し、大動脈瘤治療の世界市場規模は2030年までに104億米ドルに達し、2022年から2030年まで10.51%のCAGRで拡大すると予想されています。

先進国における老年人口の増加、座りがちなライフスタイルの急速な普及、たばこ喫煙者の増加が、世界市場を牽引する主要因になると予想されます。米国心臓協会（American Heart Association Inc.）が発表した研究によると、4cm以上のAAAsの過剰有病率の75%は喫煙が原因であると考えられていることがわかりました。さらに、血管内外科手術の技術的進歩は、業界の成長を増大させるでしょう。

特に65歳以上の男性における腹部大動脈瘤の症例数は、胸部大動脈瘤の症例数を3倍も上回りました。このため、AAA用の高度なステントグラフトシステムに対する需要が高まっています。複数の治療オプションがなく、複雑な手術であるため、TAA手術の件数は少なくなっています。このため、メーカーは胸部血管内膜瘤修復術（TEVAR）用の高度な製品を開発するための有利な機会を得ています。

COVID-19の大流行がAA市場にマイナスの影響を及ぼしました。米国外科学会やフランス血管外科学会など多くの政府機関が、合併症を伴わないAA手術の延期を推奨しました。多くの病院が大動脈疾患に関連する手術を制限し、開腹手術よりもEAVRが好まれました。その結果、大動脈疾患治療機器の売上は激減しました。例えば、Microport Scientific Corporationの血管内セグメントは、2021年に42.1%の収益減少となっています。

大動脈瘤市場レポートハイライト

タイプ別では、2021年にAAAセグメントが市場を独占しました。AAA症例数の増加、早期スクリーニングのための政府プログラムの存在、低侵襲手術の需要増が、同セグメントを牽引している

製品別では、ステントグラフトが患者の外科治療費全体に占める割合が50％を超えていることから、2021年に最大の収益シェアを占めた

エンドユーザー別では、技術進歩や手術件数の増加により病院向けが好調と予測

治療法別では、低侵襲手術を含む血管内大動脈瘤修復術（EVAR）が、術後の副作用が少なく開腹修復よりも効率的であることから、予測期間中に最も成長するセグメントとなる見込みです。

2021年の売上高シェアは北米が最も大きく、次いで欧州が続く。これは、医療インフラが確立されていること、AAAに対する高度なスクリーニングおよび診断ツールを利用できること、および同地域における良好な償還シナリオが理由である

2021年8月、テルモ株式会社は、胸部大動脈瘤および浸透性動脈硬化性潰瘍の患者を治療するためのRelayPro Thoracic Stent-Graft Systemの米国における販売承認を米国FDAより取得しました。

目次

第1章 調査範囲と目的

  • 市場セグメンテーション
  • 地域範囲
  • 調査目的

第2章 調査手法

  • 調査手法
    • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • ボリューム価格分析
  • 二次情報一覧
  • 略語一覧

第3章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
    • タイプ
    • 処理
    • 製品
    • 最終用途
  • 地域の見通し
  • 競合考察

第4章 市場変数、動向、範囲

  • 市場系列の見通し
    • 親市場の見通し
    • 関連/補助的な市場の見通し
  • 大動脈瘤市場力学
    • 市場促進要因分析
    • 市場制約分析
  • 大動脈瘤市場：事業環境分析ツール
    • ポーターのファイブフォース分析
      • 新規参入業者の脅威
      • 買い手の交渉力
      • 競争企業間の敵対関係
      • 代替品の脅威
      • 供給企業の交渉力
    • PESTLE分析
      • 政治と法律
      • 経済と社会
      • 技術的な
  • 浸透と成長の見通しのマッピング
  • 定性分析：大動脈瘤市場に対するCOVID-19の影響

第5章 大動脈瘤市場：タイプ分析

  • 大動脈瘤タイプの市場シェア分析、2021年および2030年
  • 大動脈瘤タイプの市場：セグメントダッシュボード
  • タイプセグメントの市場規模と予測、トレンド分析、2016～2030年
    • 胸部大動脈瘤（TAA）
    • 腹部大動脈瘤（AAA）

第6章 大動脈瘤市場：治療分析

  • 大動脈瘤治療の市場シェア分析、2021年および2030年
  • 大動脈瘤治療市場：セグメントダッシュボード
  • 2016年から2030年までの治療セグメントの市場規模と予測、トレンド分析
    • オープンサージカルリペア（OSR）
    • 血管内動脈瘤修復（EVAR）

第7章 大動脈瘤市場：製品分析

  • 大動脈瘤製品の市場シェア分析、2021年および2030年
  • 大動脈瘤製品市場：セグメントダッシュボード
  • 製品セグメントの市場規模と予測、トレンド分析、2016～2030年
    • ステントグラフト
    • カテーテル

第8章 大動脈瘤市場：エンドユース分析

  • 大動脈瘤の最終用途の市場シェア分析、2021年および2030年
  • 大動脈瘤最終用途市場：セグメントダッシュボード
  • 最終用途セグメントの市場規模と予測、およびトレンド分析、2016～2030年
    • 病院
    • 外来手術センター
    • 診療所

第9章 大動脈瘤市場：地域分析

  • 大動脈瘤の地域市場シェア分析、2021年および2030年
  • 地域市場のスナップショット
  • 市場規模、予測、トレンド分析、2016年から2030年
    • 北米
      • 米国
      • カナダ
    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
    • アジア太平洋地域
      • 日本
      • 中国
      • インド
      • オーストラリア
      • 韓国
    • ラテンアメリカ
      • メキシコ
      • ブラジル
    • 中東とアフリカ
      • 南アフリカ
      • サウジアラビア

第10章 競合分析

  • 主要な市場参加者別最近の動向と影響分析
  • 競合の分類（主要なイノベーター、マーケットリーダー、新興企業）
  • 会社の市況分析
  • 企業プロファイル
    • MEDTRONIC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • TERUMO CORPORATION
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • ENDOLOGIX LLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • MICROPORT SCIENTIFIC CORPORATION
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • GORE MEDICAL（WL GORE &ASSOCIATES）
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • COOK
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • JOTEC（CRYOLIFE, INC.）
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • LOMBARD MEDICAL
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 North America Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 4 North America Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 5 North America Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 6 North America Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 7 North America Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 8 U.S. Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 9 U.S. Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 10 U.S. Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 11 U.S. Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 12 Canada Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 13 Canada Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 14 Canada Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 15 Canada Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 16 Europe Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 17 Europe Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 18 Europe Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 19 Europe Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 20 Europe Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 21 U.K. Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 22 U.K. Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 23 U.K. Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 24 U.K. Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 25Germany Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 26 Germany Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 27 Germany North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 28 Germany Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 29 France Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 30 France Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 31 France North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 32 France Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 33 Italy Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 34 Italy Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 35 Italy North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 36 Italy Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 37 Spain Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 38 Spain Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 39 Spain North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 40 Spain Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 41 Asia Pacific Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 42 Asia Pacific Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 43 Asia Pacific Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 44 Asia Pacific Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 45 Asia Pacific Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 46 Japan Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 47 Japan Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 48 Japan Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 49 Japan Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 50 China Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 51 China Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 52 China Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 53 China Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 54 India Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 55 India Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 56 India Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 57 India Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 58 Australia Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 59 Australia Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 60 Australia Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 61 Australia Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 62 South Korea Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 63 South Korea Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 64 South Korea Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 65 South Korea Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 66 Latin America Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 67 Latin America Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 68 Latin America Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 69 Latin America Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 70 Latin America Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 71 Brazil Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 72 Brazil Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 73 Brazil Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 74 Brazil Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 75 Mexico Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 76 Mexico Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 77 Mexico Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 78 Mexico Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 79 Middle East & Africa Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 80 Middle East & Africa Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 81 Middle East & Africa Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 82 Middle East & Africa Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 83 Middle East & Africa Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 84 South Africa Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 85 South Africa Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 86 South Africa Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 87 South Africa Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 88 Saudi Arabia Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 89 Saudi Arabia Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 90 Saudi Arabia Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 91 Saudi Arabia Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market outlook
  • FIG. 9 Aortic aneurysm market segmentation
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 Market dynamics
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 Aortic aneurysm type market share analysis, 2021 & 2030
  • FIG. 15 Aortic aneurysm type market: Segment dashboard
  • FIG. 16 Thoracic aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 17 Abdominal aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 18 Aortic aneurysm treatment type market share analysis, 2021 & 2030
  • FIG. 19 Aortic aneurysm treatment type market: Segment dashboard
  • FIG. 20 Open surgical repair market, 2016 - 2030 (USD Million)
  • FIG. 21 Endovascular aneurysm repair(EVAR), 2016 - 2030 (USD Million)
  • FIG. 22 Aortic aneurysm product market share analysis, 2021 & 2030
  • FIG. 23 Aortic Aneurysm Product Market: Segment dashboard
  • FIG. 24 Stent grafts market, 2016 - 2030 (USD Million)
  • FIG. 25 Catheters market, 2016 - 2030 (USD Million)
  • FIG. 26 Aortic aneurysm product market share analysis, 2021 & 2030
  • FIG. 27 Aortic aneurysm product market: Segment dashboard
  • FIG. 28 Hospitals market, 2016 - 2030 (USD Million)
  • FIG. 29 Ambulatory surgery centers market, 2016 - 2030 (USD Million)
  • FIG. 30 Clinics market, 2016 - 2030 (USD Million)
  • FIG. 31 Aortic aneurysm regional market share analysis, 2021 & 2030
  • FIG. 32 Aortic aneurysm regional market: Segment dashboard
  • FIG. 33 Regional marketplace: Key takeaways
  • FIG. 34 North America aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 35 U.S. aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 36 Canada aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 37 Europe aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 38 U.K.. aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 39 Germany aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 40 France aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 41 Italy aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 42 Spain aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 43 Asia Pacific aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 44 Japan aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 45 China aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 46 India aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 47 Australia aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 48 South Korea aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 49 Latin America aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 50 Brazil aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 51 Mexico aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 52 MEA aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 53South Africa aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 54 Saudi Arabia aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 55 Recent developments & impact analysis, by key market participants
  • FIG. 56 Strategic framework/ competition categorization
  • FIG. 57 Company market position analysis
目次
Product Code: GVR-3-68038-043-9

Aortic Aneurysm Market Growth & Trends:

The global aortic aneurysm market size is expected to reach USD 6.5 billion by 2030 and the global aortic aneurysm treatment market size is expected to reach USD 10.4 billion by 2030, expanding at a CAGR of 10.51% from 2022 to 2030, according to a new report by Grand View Research, Inc.

The growing geriatric population in developed countries, rapid adoption of sedentary lifestyles, and a rise in the number of tobacco smokers are expected to be the key factors driving the global market. According to a study published by the American Heart Association Inc., it was found that smoking was considered to be responsible for 75% of the excess prevalence of AAAs ≥4 cm. Furthermore, technological advancements in endovascular surgical procedures will augment the industry's growth.

Cases of abdominal aortic aneurysms, especially in men aged 65 years and above, surpassed the number of thoracic aortic aneurysms by threefold. This has increased the demand for advanced stent-graft systems for AAA. Due to the lack of multiple treatment options and being a complex procedure, TAA procedures are fewer. This offers a lucrative opportunity to the manufacturers for developing advanced products for Thoracic Endovascular Aneurysm Repair (TEVAR).

The COVID-19 pandemic negatively impacted the AA market. Many government associations such as the American College of Surgeons and the French Vascular Surgical Society recommended the postponement of uncomplicated AA procedures. Many hospitals limited surgical activity related to aortic diseases, with EAVR being preferred over open surgery. As a result, the sales of AA devices reported a sharp decline. For instance, the endovascular segment of Microport Scientific Corporation witnessed a decline of 42.1% in revenue in 2021.

Aortic Aneurysm Market Report Highlights:

  • Based on type, the AAA segment dominated the market in 2021. The rising number of AAA cases, the presence of government programs for early screening, and increasing demand for minimally invasive procedures are driving the segment
  • In terms of product, stent-grafts held the largest revenue share in 2021 as they have more than 50% share in the overall surgical treatment cost of a patient
  • Based on end-use, the hospital's segment is expected to flourish owing to a rise in technological advancement and high procedure volume
  • By treatment, Endovascular Aortic Aneurysm Repair (EVAR), which includes minimally invasive surgeries, is expected to be the fastest-growing segment over the forecast period as it is more efficient than open repair due to fewer postsurgical adverse effects
  • North America held the largest revenue share in 2021, followed by Europe, on account of well-established healthcare infrastructure, access to advanced screening and diagnostic tools for AAA, and favorable reimbursement scenario in the region
  • In August 2021, Terumo Corporation received approval by the U.S. FDA for its RelayPro Thoracic Stent-Graft System to be sold in the U.S. to treat patients with thoracic aortic aneurysm and penetrating atherosclerotic ulcers

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Research Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2

Chapter 2 Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information procurement
    • 2.1.2 Purchased Database
    • 2.1.3 GVR's Internal Database
    • 2.1.4 Secondary Sources
    • 2.1.5 Primary Research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data Analysis Models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Volume Price Analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Abbreviations

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 Type
    • 3.2.2 Treatment
    • 3.2.3 Product
    • 3.2.4 End-use
  • 3.3 Regional Outlook
  • 3.4 Competitive Insights

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Related/Ancillary Market Outlook
  • 4.2 Aortic Aneurysm Market Dynamics
    • 4.2.1 Market Driver Analysis
    • 4.2.2 Market Restraint Analysis
  • 4.3 Aortic Aneurysm Market: Business Environment Analysis Tools
    • 4.3.1 Porter's five forces analysis
      • 4.3.1.1 Threat of new entrants
      • 4.3.1.2 Bargaining power of buyers
      • 4.3.1.3 Competitive rivalry
      • 4.3.1.4 Threat of substitutes
      • 4.3.1.5 Bargaining power of suppliers
    • 4.3.2 PESTLE Analysis
      • 4.3.2.1 Political & legal
      • 4.3.2.2 Economic & Social
      • 4.3.2.3 Technological
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Qualitative Analysis: Impact of COVID-19 on Aortic Aneurysm Market

Chapter 5 Aortic Aneurysm Market: Type Analysis

  • 5.1 Aortic Aneurysm Type Market Share Analysis, 2021 & 2030
  • 5.2 Aortic Aneurysm Type Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the Type Segment
    • 5.3.1 Thoracic Aortic Aneurysm (TAA)
      • 5.3.1.1 Thoracic aortic aneurysm (TAA) market, 2016 - 2030 (USD Million)
    • 5.3.2 Abdominal Aortic Aneurysm (AAA)
      • 5.3.2.1 Abdominal aortic aneurysm (AAA)market, 2016 - 2030 (USD Million)

Chapter 6 Aortic Aneurysm Market: Treatment Analysis

  • 6.1 Aortic Aneurysm TreatmentMarket Share Analysis, 2021 & 2030
  • 6.2 Aortic Aneurysm TreatmentMarket: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the TreatmentSegment
    • 6.3.1 Open Surgical Repair (OSR)
      • 6.3.1.1 Open surgical repair market, 2016 - 2030 (USD Million)
    • 6.3.2 Endovascular Aneurysm Repair (EVAR)
      • 6.3.2.1 Endovascular aneurysm repair (EVAR) market, 2016 - 2030 (USD Million)

Chapter 7 Aortic Aneurysm Market: Product Analysis

  • 7.1 Aortic Aneurysm ProductMarket Share Analysis, 2021 & 2030
  • 7.2 Aortic Aneurysm Product Market: Segment Dashboard
  • 7.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the ProductSegment
    • 7.3.1 Stent Grafts
      • 7.3.1.1 Stent grafts market, 2016 - 2030 (USD Million)
    • 7.3.2 Catheter
      • 7.3.2.1 Catheter market, 2016 - 2030 (USD Million)

Chapter 8 Aortic Aneurysm Market: End-Use Analysis

  • 8.1 Aortic Aneurysm End-Use Market Share Analysis, 2021 & 2030
  • 8.2 Aortic Aneurysm End-Use Market: Segment Dashboard
  • 8.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the End-Use Segment
    • 8.3.1 Hospitals
      • 8.3.1.1Hospitals market, 2016 - 2030 (USD Million)
    • 8.3.2 Ambulatory Surgery Centers
      • 8.3.2.1 Ambulatory surgery centers market, 2016 - 2030 (USD Million)
    • 8.3.3 Clinics
      • 8.3.3.1 Clinics market, 2016 - 2030 (USD Million)

Chapter 9 Aortic Aneurysm Market: Regional Analysis

  • 9.1 Aortic Aneurysm Regional Market Share Analysis, 2021 & 2030
  • 9.2 Regional Market Snapshot
  • 9.3 Market Size, & Forecasts and Trend Analysis, 2016 to 2030
    • 9.3.1 North America
      • 9.3.1.1 North America Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.1.2 U.S.
      • 9.3.1.2.1 U.S. Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.1.3 Canada
      • 9.3.1.3.1 Canada Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.2 Europe
      • 9.3.2.1 Europe Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.2 U.K.
      • 9.3.2.2.1 U.K. Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.3 Germany
      • 9.3.2.3.1 Germany Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.4 France
      • 9.3.2.4.1 France Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.5 Italy
      • 9.3.2.5.1 Italy Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.6 Spain
      • 9.3.2.6.1 Spain Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.3 Asia Pacific
      • 9.3.3.1 Asia Pacific Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.2 Japan
      • 9.3.3.2.1 Japan Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.3 China
      • 9.3.3.3.1 China Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.4 India
      • 9.3.3.4.1 India Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.5 Australia
      • 9.3.3.5.1 Australia Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.6 South Korea
      • 9.3.3.6.1South Korea Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.4 Latin America
      • 9.3.4.1 Latin America Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.4.2 Mexico
      • 9.3.4.2.1 Mexico Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.4.3 Brazil
      • 9.3.4.3.1 Brazil Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.5 Middle East & Africa
      • 9.3.5.1 MiddleEast & Africa Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.5.2 South Africa
      • 9.3.5.2.1 South Africa Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.5.3 Saudi Arabia
      • 9.3.5.3.1 Saudi Arabia Aortic Aneurysm Market, 2016 - 2030 (USD Million)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 10.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 10.3 Company Market Position Analysis
  • 10.4 company profiles
    • 10.4.1 MEDTRONIC
      • 10.4.1.1 Company overview
      • 10.4.1.2 Financial performance
      • 10.4.1.3 Product benchmarking
      • 10.4.1.4 Strategic initiatives
    • 10.4.2 TERUMO CORPORATION
      • 10.4.2.1 Company overview
      • 10.4.2.2 Financial performance
      • 10.4.2.3 Product benchmarking
      • 10.4.2.4 Strategic initiatives
    • 10.4.3 ENDOLOGIX LLC
      • 10.4.3.1 Company overview
      • 10.4.3.2 Financial performance
      • 10.4.3.3 Product benchmarking
      • 10.4.3.4 Strategic initiatives
    • 10.4.4 MICROPORT SCIENTIFIC CORPORATION
      • 10.4.4.1 Company overview
      • 10.4.4.2 Financial performance
      • 10.4.4.3 Product benchmarking
      • 10.4.4.4 Strategic initiatives
    • 10.4.5 GORE MEDICAL (W. L. GORE & ASSOCIATES)
      • 10.4.5.1 Company overview
      • 10.4.5.2 Financial performance
      • 10.4.5.3 Product benchmarking
      • 10.4.5.4 Strategic initiatives
    • 10.4.6 COOK
      • 10.4.6.1 Company overview
      • 10.4.6.2 Financial performance
      • 10.4.6.3 Product benchmarking
      • 10.4.6.4 Strategic initiatives
    • 10.4.7 JOTEC (CRYOLIFE, INC.)
      • 10.4.7.1 Company overview
      • 10.4.7.2 Financial performance
      • 10.4.7.3 Product benchmarking
      • 10.4.7.4 Strategic initiatives
    • 10.4.8 LOMBARD MEDICAL
      • 10.4.8.1 Company overview
      • 10.4.8.2 Financial performance
      • 10.4.8.3 Product benchmarking
      • 10.4.8.4 Strategic initiatives